Clinical Trial Update: Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel in early breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• fluorouracil, epirubicin, and cyclophosphamide

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED